GlycoDesign acquires Vascular Therapeutics
Article Abstract:
Mountain View, CA-based Vascular Therapeutics Inc was purchased by Toronto, Canada-based GlycoDesign Inc for five million common sharesworth C$15 million. Jeremy Carver, GlycoDesign's president, said the deal merges GlycoDesign's expertise in glycotherapeutics with Vascular Therapeutics' development of glucotherapeutics that prevent and treat cardiovascular disease.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Glaxo bids for ID Biomedical
Article Abstract:
Flu vaccine manufacturer ID Biomedical Corp. has agreed to a $1.7 billion acquisition by GlaxoSmithKline Public Limited Company. But analysts and investors claim the acquisition bid not reasonable.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Newmont sends signal that size does matter. AngloGold bids for Normandy. Newmont snags Battle Mountain
- Abstracts: TD acquires English brokerage. Pension funds slam budget's trust cap
- Abstracts: Gowling merges with two smaller practices. Gowlings cements giant merger. Fraser Milner to merge with Byers Casgrain
- Abstracts: Canada cast as caviar producer. Air Canada to form regional network. Maple Leaf designs pigs for markets
- Abstracts: NetZero invades Canada with free Net access. The push for wirelessware